Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy.
Zuo GF, Ren XM, Ge Q, Luo J, Ye P, Wang F, Wu W, Chao YL, Gu Y, Gao XF, Ge Z, Gao HB, Hu ZY, Zhang JJ, Chen SL.
Zuo GF, et al. Among authors: wu w.
J Mol Cell Cardiol. 2019 May;130:170-183. doi: 10.1016/j.yjmcc.2019.04.011. Epub 2019 Apr 15.
J Mol Cell Cardiol. 2019.
PMID: 30998977